Clinical Trials
3 trialsNCT00195260 2013-02-11
Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors
Pfizer
Phase 1 Completed
NCT01001936 2009-10-27
Study Evaluating SKI-606 in Subject With Solid Tumors
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 1 Completed
NCT00777530 2008-10-23
Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 1 Completed